BAMCO Inc
PTCT icon

BAMCO Inc’s PTC Therapeutics PTCT Stock Holding History

BAMCO Inc’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-708,697
Closed -$33.6M – 417
2021
Q1 		$33.6M Sell
708,697
-191,413
-21% -$11.4M 0.08% 179
2020
Q4 		$54.9M Buy
900,110
+54,440
+6% +$3.21M 0.14% 133
2020
Q3 		$39.5M Buy
845,670
+194,823
+30% +$9.59M 0.12% 139
2020
Q2 		$33M Buy
650,847
+506,302
+350% +$24.9M 0.12% 143
2020
Q1 		$6.45M Buy
144,545
+141,270
+4,314% +$7.11M 0.03% 221
2019
Q4 		$157K Buy
+3,275
New +$139K ﹤0.01% 323

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BAMCO Inc's PTCT Position: Q2 2021 in Review

BAMCO Inc sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 708,697 shares — an estimated $33.6M sold.

BAMCO Inc first reported a position in PTCT in Q4 2019 and held it in 6 quarters. The position peaked at $54.9M in Q4 2020. 183 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • BAMCO Inc reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • BAMCO Inc sold 708,697 PTC Therapeutics shares in Q2 2021, an estimated $33.6M.
  • BAMCO Inc first reported a position in PTC Therapeutics in Q4 2019 and held it in 6 quarters.
  • BAMCO Inc's PTC Therapeutics position peaked at $54.9M in Q4 2020.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on BAMCO Inc's 13F filing for Q2 2021, filed 13 Aug 2021.